News

FAIRFAX, Va, January 19, 2004 (LifeSiteNews.com) – The Genetics and IVF Institute (GIVF) in Fairfax, Virginia is conducting a FDA-endorsed clinical trial of the new Microsort technology for sex-selection via sorting of sperm before embryos are created using in-vitro fertilization (IVF). Thus far 400 couples have signed on to the trial, which is nearly half-way to completion. 

The Microsort technique for sex-selection involves using dye to mark sperm and a laser to sort the sperm based on the knowledge that sperm which will produce girls have more DNA. 

In a BBC interview on the topic of sex selection, Rachel Heath, assistant director of education for the pro-life charity Life, told the BBC news that “Children are a precious gift, and should be accepted totally unconditionally. We are concerned that children are increasingly being seen as commodities to be manufactured to specification as though they can be taken off the supermarket shelf.” 

With files from NBC News

Comments

Commenting Guidelines

LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.